• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死后心力衰竭进展的早期预测因子。

Early Predictors of Heart Failure Progression in Patients After Myocardial Infarction.

机构信息

Penza State University, Penza.

出版信息

Kardiologiia. 2020 Dec 15;60(11):1309. doi: 10.18087/cardio.2020.11.n1309.

DOI:10.18087/cardio.2020.11.n1309
PMID:33487154
Abstract

Aim      To identify early predictors for progression of chronic heart failure (CHF) in patients with ST-segment elevation myocardial infarction (STEMI).Material and methods  The study included 113 patients with STEMI aged 52 (95 % confidence interval, 36 to 65) years. 24-h ECG monitoring was performed with assessment of ventricular late potentials, QT dispersion, heart rhythm turbulence (HRT), and heart rhythm variability (HRV); XStrain 2D echocardiograpy with determination of volumetric parameters, myocardial strain characteristics and velocities; and measurement of brain natriuretic peptide (BNP) concentrations. The endpoint was CHF progression during 48 weeks of follow-up, which was observed in 26 (23 %) patients. Based on the outcome, two groups were isolated, with CHF progression (Prg) (26(23%)) and with a relatively stable CHF postinfarction course (Stb) (87 (77 %)).Results At 12 weeks following MI, the Prg group showed increases in left ventricular (LV) end-diastolic dimension (EDD) (р<0.05) and end-diastolic and end-systolic volumes (EDV, ESV), (р<0.01), and EDV and ESV indexes (EDVi and ESVi, р<0.01). In this group, global longitudinal strain (GLS) was decreased at 24 weeks (р<0.05) and global radial strain (GRS) was decreased at 48 weeks (р=0.0003). In the Prg group, values of strain parameters (GLS, global circular strain (GCS), and GRS) were lower at all times. At 7-9 days, 24 weeks, and 48 weeks, the proportion of patients with pathological HRT was higher in the Prg group (38, 27, and 19 % for the Prg group vs 14 % (р=0.006); 3,4 % (р=0.001), and 2.3 % (р=0.002) for the Stb group, respectively). Only in the Stb group, increases in HRV were observed (SDNNi by 13 % (р=0.001), rMSSD by 24 % (р=0.0002), TotP by 49 % (р=0.00002), VLfP by 23 % (р=0.003), LfP by 22 % (р=0.008), and HfP by 77 % (р=0.002). At 7-9 days of MI, the Stb group had greater values of SDANN (р=0.013) and HfP (р=0.01). CHF progression correlated with abnormal values of turbulence onset (TO), disturbed HRT, increased BNP levels and LV ESD, and low values of GLS, GCS, and GRS. Combined assessment of HRT, LV ESD, and GLS at 7-9 days after STEMI allows identifying patients with high risk for CHF progression in the next 48 weeks.Conclusion      The markers for CHF progression after STEMI include abnormal TO values, disturbed HRT, increased BNP levels and LV ESD, and low values of GLS, GCS, and GRS. The multifactor logistic regression analysis revealed early predictors of CHF in the postinfarction period, including abnormal TO, increased LV ESD, and reduced GLS.

摘要

目的

确定 ST 段抬高型心肌梗死(STEMI)患者慢性心力衰竭(CHF)进展的早期预测因子。

材料与方法

本研究纳入了 113 名年龄为 52 岁(95%置信区间:36 岁至 65 岁)的 STEMI 患者。进行了 24 小时心电图监测,评估心室晚期电位、QT 离散度、心率震荡(HRT)和心率变异性(HRV);进行了 XStrain 二维超声心动图检查,确定容积参数、心肌应变特征和速度;并测量了脑钠肽(BNP)浓度。终点是在 48 周随访期间发生 CHF 进展,共有 26 名(23%)患者发生了 CHF 进展。根据结局,将患者分为 CHF 进展组(Prg)(26 例(23%))和相对稳定的心肌梗死后 CHF 组(Stb)(87 例(77%))。

结果

在 MI 后 12 周,Prg 组左心室(LV)舒张末期内径(EDD)增加(р<0.05),舒张末期和收缩末期容积(EDV、ESV)增加(р<0.01),EDV 和 ESV 指数(EDVi 和 ESVi)增加(р<0.01)。在该组中,24 周时整体纵向应变(GLS)下降(р<0.05),48 周时整体径向应变(GRS)下降(р=0.0003)。在 Prg 组,所有时间点的应变参数(GLS、整体圆周应变(GCS)和 GRS)值均较低。在 7-9 天、24 周和 48 周时,Prg 组病理性 HRT 的患者比例更高(38%、27%和 19% vs 14%,р=0.006;3%、4%和 2.3%,р=0.001 和 р=0.002,分别)。只有在 Stb 组观察到 HRV 增加(SDNNi 增加 13%,р=0.001;rMSSD 增加 24%,р=0.0002;TotP 增加 49%,р=0.00002;VLfP 增加 23%,р=0.003;LfP 增加 22%,р=0.008;和 HfP 增加 77%,р=0.002)。在 MI 后 7-9 天,Stb 组的 SDANN(р=0.013)和 HfP(р=0.01)值更高。CHF 进展与湍流起始(TO)异常值、HRT 紊乱、BNP 水平升高和 LV ESD 以及 GLS、GCS 和 GRS 值降低相关。STEMI 后 7-9 天 HRT、LV ESD 和 GLS 的联合评估可识别出未来 48 周内 CHF 进展风险较高的患者。

结论

STEMI 后 CHF 进展的标志物包括异常的 TO 值、紊乱的 HRT、BNP 水平升高和 LV ESD 以及 GLS、GCS 和 GRS 值降低。多因素逻辑回归分析显示,心肌梗死后早期的 CHF 预测因子包括异常的 TO、LV ESD 增加和 GLS 降低。

相似文献

1
Early Predictors of Heart Failure Progression in Patients After Myocardial Infarction.心肌梗死后心力衰竭进展的早期预测因子。
Kardiologiia. 2020 Dec 15;60(11):1309. doi: 10.18087/cardio.2020.11.n1309.
2
Relationship between electrical myocardial instability and postinfarction remodeling in patients with ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死患者电心肌不稳定与梗死后重构的关系。
Kardiologiia. 2021 Oct 30;61(10):14-25. doi: 10.18087/cardio.2021.10.n1626.
3
A Multivariate Model to Predict Chronic Heart Failure after Acute ST-Segment Elevation Myocardial Infarction: Preliminary Study.预测急性ST段抬高型心肌梗死后慢性心力衰竭的多变量模型:初步研究
Diagnostics (Basel). 2021 Oct 18;11(10):1925. doi: 10.3390/diagnostics11101925.
4
Comparison of clinical and echocardiographic parameters of patients with COVID-19 pneumonia three months and one year after discharge.比较 COVID-19 肺炎患者出院后三个月和一年时的临床和超声心动图参数。
Kardiologiia. 2022 Jan 31;62(1):13-23. doi: 10.18087/cardio.2022.1.n1859.
5
Predictors of tachycardia-induced cardiomyopathy in patients with first-time decompensation of chro-nic heart failure with reduced left ventricular ejection fraction of nonischemic etiology and persistent atrial tachyarrhythmia.预测非缺血性病因和持续性房性快速性心律失常导致左心室射血分数降低的慢性心力衰竭首次失代偿患者的心动过速性心肌病。
Kardiologiia. 2022 Nov 30;62(11):56-62. doi: 10.18087/cardio.2022.11.n2262.
6
Value of three-dimensional strain parameters for predicting left ventricular remodeling after ST-elevation myocardial infarction.三维应变参数对预测ST段抬高型心肌梗死后左心室重构的价值。
Int J Cardiovasc Imaging. 2017 May;33(5):663-673. doi: 10.1007/s10554-016-1053-3. Epub 2017 Feb 1.
7
[Clinical and laboratory associations of liver fibrosis indexes in patients with decompensated Chronic Heart Failure II-IV Functional Classes].失代偿性慢性心力衰竭II-IV功能分级患者肝纤维化指标的临床及实验室关联
Kardiologiia. 2020 Jun 3;60(5):920. doi: 10.18087/cardio.2020.5.n920.
8
Correlations between clinical and laboratory findings and prognostically unfavorable CMR-based characteristics of acute ST-elevation myocardial infarction.临床和实验室检查结果与急性 ST 段抬高型心肌梗死基于 CMR 的预后不良特征之间的相关性。
Kardiologiia. 2021 Feb 10;61(1):44-51. doi: 10.18087/cardio.2021.1.n1373.
9
[Ivabradine for Treatment of Heart Failure with Preserved Ejection Fraction].伊伐布雷定用于治疗射血分数保留的心力衰竭
Kardiologiia. 2020 Oct 10;60(10):33-37. doi: 10.18087/cardio.2020.10.n1324.
10
Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial.ST 段抬高型心肌梗死早期美托洛尔对左心室应变的影响:来自 METOCARD-CNIC 试验的特征追踪心血管磁共振子研究。
JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1188-1198. doi: 10.1016/j.jcmg.2018.07.019. Epub 2018 Sep 12.

引用本文的文献

1
A diagnostic prediction model for the early detection of heart failure following primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.一种用于ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后早期心力衰竭检测的诊断预测模型。
Am J Cardiovasc Dis. 2024 Aug 25;14(4):208-219. doi: 10.62347/SHPZ1673. eCollection 2024.
2
Effect of the combined use of ivabradine and metoprolol in patients with acute myocardial infarction early after percutaneous coronary intervention: A randomized controlled study.伊伐布雷定与美托洛尔联合应用于经皮冠状动脉介入治疗后早期急性心肌梗死患者的疗效:一项随机对照研究。
Heliyon. 2024 Jun 27;10(13):e33779. doi: 10.1016/j.heliyon.2024.e33779. eCollection 2024 Jul 15.
3
Impact of congestive heart failure on patients undergoing lumbar spine fusion for adult spine deformity.
充血性心力衰竭对因成人脊柱畸形接受腰椎融合手术患者的影响。
J Craniovertebr Junction Spine. 2024 Jan-Mar;15(1):45-52. doi: 10.4103/jcvjs.jcvjs_186_23. Epub 2024 Mar 13.
4
A Multivariate Model to Predict Chronic Heart Failure after Acute ST-Segment Elevation Myocardial Infarction: Preliminary Study.预测急性ST段抬高型心肌梗死后慢性心力衰竭的多变量模型:初步研究
Diagnostics (Basel). 2021 Oct 18;11(10):1925. doi: 10.3390/diagnostics11101925.